The new results helped boost Moderna’s stock by more than 4% in early trading Monday, though the company’s shares are still ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...

A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.

A CDC panel’s vote to stop recommending thimerosal-containing flu shots would have limited impact, but it illustrates how the ...

The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.

The Trump administration’s vaccine advisers are bringing up an old flu-shot debate: whether it’s time to wipe out the last ...

U.S. Health Secretary Robert F. Kennedy Jr.’s new vaccine advisory committee endorsed fall flu vaccinations Thursday for just ...

Moderna’s mRNA flu shot outperforms existing vaccines in Phase 3 trial, showing over 26% greater efficacy—paving the way for ...

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.